ChiCTR1900026244
尚未开始
/
/
/
2019-09-28
/
/
乳腺癌
乳腺癌生存者自我管理應用程式的隨機對照試驗
Breast Cancer App protocol: a randomized controlled trial to evaluate a self-management app for breast cancer survivors
1) to examine whether there is the difference in the health literacy, problem solving skills, readiness of change, self-efficacy, self-management skill, and health-related quality of life between the intervention group and the control group; 2) to examine the usability of this self-management app versus a general health app.
随机平行对照
探索性研究/预试验
SPSS (IBM SPSS Statistics Version 25) will be used to generate the random sequence for group allocation.
Not addressed
Departmental research fund
/
244
/
2020-01-01
2021-06-30
/
1) female; 2) breast cancer survivors; 3) Cancer stages I to III; 4) completion of primary treatment within one year or longer; 5) aged 18 to 65 years; 6) acceptable literacy level (e.g. able to read, and write Chinese); 7) agree for checking of usage log of mobile app; 8) able to provide informed consent.；
请登录查看1) BCS diagnosed with severe mental illnesses; 2) Diagnosis of another cancer type rather than breast cancer; 3) has already participated in other clinical trial; 4) has been used other self-management app to manage the breast cancer.；
请登录查看香港理工大學康復科學系
/
香港理工大學康復科學系的其他临床试验
香港理工大學康復科學系的其他临床试验
最新临床资讯
-
诺华：CFB抑制剂终止狼疮肾炎二期临床
医药笔记2026-10-17
-
泽安生物医药：实体瘤MCE启动一期临床
医药笔记2026-10-17
-
药明康德2026-10-17
-
沃森生物2026-10-16
-
罕见病信息网2026-10-16
-
武警特色医学中心2026-10-16
-
生物经纬2026-10-16
-
良医汇肿瘤资讯2026-10-16
-
BioMed科技2026-10-16
-
蒲公英资讯2026-10-16
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-10-26
-
2026-10-25
-
2026-10-25
-
摩熵咨询 33 51
-
摩熵咨询 20 3
-
摩熵咨询 20 10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
-
颁布机构：国家药品监督管理局药品审评中心 2026-09-28
-
颁布机构：国家药品监督管理局 2026-09-10
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-10-23
-
2026-10-23
-
2026-10-21
-
摩熵咨询 35 83
-
摩熵咨询 28 71
-
摩熵咨询 34 47
-
颁布机构：国家药品监督管理局 2026-10-19
-
颁布机构：国家市场监督管理总局 2026-10-16
-
颁布机构：国家市场监督管理总局 2026-09-30